Cargando…

Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study

BACKGROUND: Few studies have reported the long-term health effects of COVID-19. The regional population-based Linköping COVID-19 study (LinCoS) included all patients hospitalised due to COVID-19 during the first pandemic wave. Four months post-discharge, over 40% (185/433) experienced persisting sym...

Descripción completa

Detalles Bibliográficos
Autores principales: Wahlgren, Carl, Forsberg, Gustaf, Divanoglou, Anestis, Östholm Balkhed, Åse, Niward, Katarina, Berg, Sören, Levi, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951394/
https://www.ncbi.nlm.nih.gov/pubmed/36855599
http://dx.doi.org/10.1016/j.lanepe.2023.100595
_version_ 1784893380954685440
author Wahlgren, Carl
Forsberg, Gustaf
Divanoglou, Anestis
Östholm Balkhed, Åse
Niward, Katarina
Berg, Sören
Levi, Richard
author_facet Wahlgren, Carl
Forsberg, Gustaf
Divanoglou, Anestis
Östholm Balkhed, Åse
Niward, Katarina
Berg, Sören
Levi, Richard
author_sort Wahlgren, Carl
collection PubMed
description BACKGROUND: Few studies have reported the long-term health effects of COVID-19. The regional population-based Linköping COVID-19 study (LinCoS) included all patients hospitalised due to COVID-19 during the first pandemic wave. Four months post-discharge, over 40% (185/433) experienced persisting symptoms and activity/participation limitations, indicating post-COVID-19 condition (PCC). The present follow-up study aimed to determine the long-term recovery among these patients 24 months post-admission. METHODS: This prospective cohort study included all patients from LinCoS with PCC at four months post-discharge. We repeated the same structured interview at a 24-month follow-up to identify persisting symptoms and their impact on daily life. Intercurrent health issues were identified by reviewing medical records. FINDINGS: Of 185 patients with PCC at 4 months post-discharge, 181 were alive at the 24-month assessment and 165 agreed to participate. Of those, 21% (35/165) had been readmitted to hospital for various causes in the interim period. The majority of patients (139/165, 84%) reported persisting problems affecting everyday life at 24 months. Significant improvements were seen in the prevalence and magnitude of some symptoms/limitations compared with four months post-discharge. Cognitive, sensorimotor, and fatigue symptoms were the most common persisting symptoms at 24 months. No clear difference was evident between individuals treated in the intensive care unit (ICU) and non-ICU-treated individuals. Approximately half of those who were on sick leave related to PCC at four months after infection were on sick leave at 24 months. INTERPRETATION: This is one of the first studies to report 2-year outcomes in patients with PCC following COVID-19 hospitalisation. Despite some improvements over time, we found a high prevalence of persisting symptoms and a need for long-term follow-up and rehabilitation post COVID-19 infection. FUNDING: The study was funded by 10.13039/100016670Region Östergötland.
format Online
Article
Text
id pubmed-9951394
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99513942023-02-24 Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study Wahlgren, Carl Forsberg, Gustaf Divanoglou, Anestis Östholm Balkhed, Åse Niward, Katarina Berg, Sören Levi, Richard Lancet Reg Health Eur Articles BACKGROUND: Few studies have reported the long-term health effects of COVID-19. The regional population-based Linköping COVID-19 study (LinCoS) included all patients hospitalised due to COVID-19 during the first pandemic wave. Four months post-discharge, over 40% (185/433) experienced persisting symptoms and activity/participation limitations, indicating post-COVID-19 condition (PCC). The present follow-up study aimed to determine the long-term recovery among these patients 24 months post-admission. METHODS: This prospective cohort study included all patients from LinCoS with PCC at four months post-discharge. We repeated the same structured interview at a 24-month follow-up to identify persisting symptoms and their impact on daily life. Intercurrent health issues were identified by reviewing medical records. FINDINGS: Of 185 patients with PCC at 4 months post-discharge, 181 were alive at the 24-month assessment and 165 agreed to participate. Of those, 21% (35/165) had been readmitted to hospital for various causes in the interim period. The majority of patients (139/165, 84%) reported persisting problems affecting everyday life at 24 months. Significant improvements were seen in the prevalence and magnitude of some symptoms/limitations compared with four months post-discharge. Cognitive, sensorimotor, and fatigue symptoms were the most common persisting symptoms at 24 months. No clear difference was evident between individuals treated in the intensive care unit (ICU) and non-ICU-treated individuals. Approximately half of those who were on sick leave related to PCC at four months after infection were on sick leave at 24 months. INTERPRETATION: This is one of the first studies to report 2-year outcomes in patients with PCC following COVID-19 hospitalisation. Despite some improvements over time, we found a high prevalence of persisting symptoms and a need for long-term follow-up and rehabilitation post COVID-19 infection. FUNDING: The study was funded by 10.13039/100016670Region Östergötland. Elsevier 2023-02-24 /pmc/articles/PMC9951394/ /pubmed/36855599 http://dx.doi.org/10.1016/j.lanepe.2023.100595 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles
Wahlgren, Carl
Forsberg, Gustaf
Divanoglou, Anestis
Östholm Balkhed, Åse
Niward, Katarina
Berg, Sören
Levi, Richard
Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study
title Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study
title_full Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study
title_fullStr Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study
title_full_unstemmed Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study
title_short Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study
title_sort two-year follow-up of patients with post-covid-19 condition in sweden: a prospective cohort study
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951394/
https://www.ncbi.nlm.nih.gov/pubmed/36855599
http://dx.doi.org/10.1016/j.lanepe.2023.100595
work_keys_str_mv AT wahlgrencarl twoyearfollowupofpatientswithpostcovid19conditioninswedenaprospectivecohortstudy
AT forsberggustaf twoyearfollowupofpatientswithpostcovid19conditioninswedenaprospectivecohortstudy
AT divanoglouanestis twoyearfollowupofpatientswithpostcovid19conditioninswedenaprospectivecohortstudy
AT ostholmbalkhedase twoyearfollowupofpatientswithpostcovid19conditioninswedenaprospectivecohortstudy
AT niwardkatarina twoyearfollowupofpatientswithpostcovid19conditioninswedenaprospectivecohortstudy
AT bergsoren twoyearfollowupofpatientswithpostcovid19conditioninswedenaprospectivecohortstudy
AT levirichard twoyearfollowupofpatientswithpostcovid19conditioninswedenaprospectivecohortstudy